WO2025120231 - ANTIFUNGAL COMPOUNDS
National phase entry is expected:
Publication Number
WO/2025/120231
Publication Date
12.06.2025
International Application No.
PCT/EP2024/085332
International Filing Date
09.12.2024
Title **
[English]
ANTIFUNGAL COMPOUNDS
[French]
COMPOSÉS ANTIFONGIQUES
Applicants **
KATHOLIEKE UNIVERSITEIT LEUVEN
Inventors
VAN DIJCK, Patrick
NYSTEN, Jana
DEMUYSER, Liesbeth
Priority Data
23215322.1
08.12.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1882 | |
| EPO | Filing, Examination, Granting | 8131 | |
| Japan | Filing, Examination, Granting | 2006 | |
| South Korea | Filing, Examination, Granting | 1747 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
18,506
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The invention relates to compounds for use in the treatment or prevention of a fungal infection in a subject.[French]
L'invention concerne des composés destinés à être utilisés pour traiter ou prévenir une infection fongique chez un sujet.